Sabra Healthcare REIT (NASDAQ:SBRA) Price Target Raised to $25.00

Sabra Healthcare REIT (NASDAQ:SBRA) had its price objective increased by Citizens Jmp from $23.00 to $25.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has a market outperform rating on the real estate investment trust’s stock.

A number of other research firms also recently weighed in on SBRA. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Sabra Healthcare REIT in a research note on Wednesday. Cantor Fitzgerald lifted their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. Scotiabank dropped their target price on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating for the company in a research report on Thursday, June 18th. Finally, UBS Group set a $25.00 price target on Sabra Healthcare REIT in a research note on Wednesday. Eight investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $22.25.

Sabra Healthcare REIT Price Performance

Sabra Healthcare REIT stock opened at $22.36 on Wednesday. The business’s 50-day simple moving average is $19.68 and its 200 day simple moving average is $19.84. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96. The stock has a market cap of $5.64 billion, a price-to-earnings ratio of 35.49, a P/E/G ratio of 1.57 and a beta of 0.65. Sabra Healthcare REIT has a 12-month low of $17.17 and a 12-month high of $22.55.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, hitting the consensus estimate of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. During the same period in the previous year, the business posted $0.37 EPS. The company’s quarterly revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, research analysts anticipate that Sabra Healthcare REIT will post 1.5 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.4%. The ex-dividend date was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 190.48%.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of SBRA. Vanguard Group Inc. increased its stake in Sabra Healthcare REIT by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 35,430,016 shares of the real estate investment trust’s stock valued at $671,045,000 after purchasing an additional 481,231 shares in the last quarter. Principal Financial Group Inc. boosted its position in shares of Sabra Healthcare REIT by 0.4% during the first quarter. Principal Financial Group Inc. now owns 25,052,121 shares of the real estate investment trust’s stock worth $481,755,000 after purchasing an additional 98,770 shares in the last quarter. Nuveen LLC boosted its position in shares of Sabra Healthcare REIT by 28.6% during the fourth quarter. Nuveen LLC now owns 7,303,254 shares of the real estate investment trust’s stock worth $138,324,000 after purchasing an additional 1,625,072 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Sabra Healthcare REIT by 2.9% in the 4th quarter. Geode Capital Management LLC now owns 7,018,556 shares of the real estate investment trust’s stock valued at $132,949,000 after buying an additional 198,118 shares during the period. Finally, Bank of America Corp DE increased its position in shares of Sabra Healthcare REIT by 9.4% in the 3rd quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock valued at $97,378,000 after buying an additional 447,528 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.